BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21104786)

  • 1. Assessing departure from dose linearity under a repeated measures incomplete block design.
    Cheng B; Chow SC
    Pharm Stat; 2011; 10(4):357-62. PubMed ID: 21104786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the assessment of dose proportionality: a comparison of two slope approaches.
    Cheng B; Chow SC; Su WL
    J Biopharm Stat; 2006 May; 16(3):385-92. PubMed ID: 16724492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sample size calculation for the Power Model for dose proportionality studies.
    Sethuraman VS; Leonov S; Squassante L; Mitchell TR; Hale MD
    Pharm Stat; 2007; 6(1):35-41. PubMed ID: 17323313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple-arm superiority and non-inferiority designs with various endpoints.
    Chang M
    Pharm Stat; 2007; 6(1):43-52. PubMed ID: 17323311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sample size/power calculations for population pharmacodynamic experiments involving repeated-count measurements.
    Ogungbenro K; Aarons L
    J Biopharm Stat; 2010 Sep; 20(5):1026-42. PubMed ID: 20721789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of dose-response in flexible dose titration clinical studies.
    Xu XS; Yuan M; Nandy P
    Pharm Stat; 2012; 11(4):280-6. PubMed ID: 22407972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cumulative statistical power for hierarchical comparisons to evaluate two combination drug doses.
    Matsukura T; Koch GG
    J Biopharm Stat; 2008; 18(4):750-72. PubMed ID: 18607806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing non-inferiority and superiority for two endpoints for several treatments with a control.
    Lawrence J
    Pharm Stat; 2011; 10(4):318-24. PubMed ID: 20949636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A note on power and sample size calculations for the Kruskal-Wallis test for ordered categorical data.
    Fan C; Zhang D
    J Biopharm Stat; 2012; 22(6):1162-73. PubMed ID: 23075015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sample size estimation for GEE method for comparing slopes in repeated measurements data.
    Jung SH; Ahn C
    Stat Med; 2003 Apr; 22(8):1305-15. PubMed ID: 12687656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exact sample-size determination in testing non-inferiority under a simple crossover trial.
    Lui KJ; Chang KC
    Pharm Stat; 2012; 11(2):129-34. PubMed ID: 22232060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and sample size for evaluating combinations of drugs of linear and loglinear dose-response curves.
    Fang HB; Tian GL; Li W; Tan M
    J Biopharm Stat; 2009 Jul; 19(4):625-40. PubMed ID: 20183430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New tests for null hypothesis of non unity ratio of proportions.
    Koti KM
    J Biopharm Stat; 2007; 17(2):229-45. PubMed ID: 17365220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing non-inferiority of a new treatment in a three-arm clinical trial including a placebo.
    Pigeot I; Schäfer J; Röhmel J; Hauschke D
    Stat Med; 2003 Mar; 22(6):883-99. PubMed ID: 12627407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-parametric assessment of non-inferiority with censored data.
    Freitag G; Lange S; Munk A
    Stat Med; 2006 Apr; 25(7):1201-17. PubMed ID: 16345041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating dose equivalence for new routes of drug administration.
    Weerakkody G; Gonzales C; Muchmore D; Chien J
    J Biopharm Stat; 2004 Nov; 14(4):1021-36. PubMed ID: 15587978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Test for the consistency of noninferiority from multiple clinical trials.
    Yan X; Wang MC; Su X
    J Biopharm Stat; 2007; 17(2):265-78. PubMed ID: 17365223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A point estimator for the time course of drug release.
    Koehne-Voss S; Pigeot I
    Biom J; 2009 Feb; 51(1):146-58. PubMed ID: 19219906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed noninferiority margin and statistical tests in active controlled trials.
    Tsou HH; Hsiao CF; Chow SC; Yue L; Xu Y; Lee S
    J Biopharm Stat; 2007; 17(2):339-57. PubMed ID: 17365228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptive design and estimation in randomized clinical trials with correlated observations.
    Yin G; Shen Y
    Biometrics; 2005 Jun; 61(2):362-9. PubMed ID: 16011682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.